Alan Webster
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Genetics top 0.5%
- Estrogen and related hormone effects
Papers in
- Genetics 18
- Estrogen and related hormone effects 18
-
- Lung Cancer Treatments and Mutations 5
- Prostate Cancer Treatment and Research 1
- Co-authors
- Aman U. Buzdar (10 shared papers)Mark L. Steinberg (9 shared papers)Anthony Howell (8 shared papers)John F.R. Robertson (8 shared papers)Stephen E. Jones (7 shared papers)Mia von Euler (4 shared papers)L. Mauriac (5 shared papers)Ignace B. Vergote (4 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer (6 papers)Wildlife Research (2 papers)European Journal of Cancer (2 papers)European Thyroid Journal (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Alan Webster
31 papers receiving 6.0k citations
Alan Webster's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 2.4k
- Genetics 3.3k
- Oncology 2.8k
- Pulmonary and Respiratory Medicine 2.3k
- Obstetrics and Gynecology 157
Countries citing papers authored by Alan Webster
This map shows the geographic impact of Alan Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Webster more than expected).
Fields of papers citing papers by Alan Webster
This network shows the impact of papers produced by Alan Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Webster. The network helps show where Alan Webster may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Webster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial Hit paper breakdown → | 2000 | 830 |
| 2 | Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study Hit paper breakdown → | 2000 | 686 |
| 3 | 2002 | 537 | |
| 4 | 2002 | 515 | |
| 5 | 2001 | 471 | |
| 6 | Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status Hit paper breakdown → | 2014 | 393 |
| 7 | Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group. | 1998 | 368 |
| 8 | First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study Hit paper breakdown → | 2013 | 361 |
| 9 | Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial Hit paper breakdown → | 2015 | 351 |
| 10 | 1996 | 335 | |
| 11 | 2004 | 322 | |
| 12 | 2003 | 260 | |
| 13 | Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. | 2001 | 199 |
| 14 | 1997 | 187 | |
| 15 | 1998 | 155 | |
| 16 | 1998 | 144 | |
| 17 | 1995 | 104 | |
| 18 | 2006 | 54 | |
| 19 | 2014 | 39 | |
| 20 | 2000 | 26 |
About Alan Webster
Alan Webster is a scholar working on Genetics, Pulmonary and Respiratory Medicine, Ecology, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 32 papers that have together received 6.5k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (18 papers), Lung Cancer Treatments and Mutations (5 papers), Avian ecology and behavior (4 papers), Animal Ecology and Behavior Studies (4 papers), Wildlife Ecology and Conservation (4 papers), Breast Cancer Treatment Studies (3 papers), Ecology and Vegetation Dynamics Studies (2 papers) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (2.4k citations), Genetics (3.3k citations), Oncology (2.8k citations), Pulmonary and Respiratory Medicine (2.3k citations) and Obstetrics and Gynecology (157 citations). Alan Webster has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Aman U. Buzdar, Mark L. Steinberg, Anthony Howell, John F.R. Robertson, Stephen E. Jones, Mia von Euler, L. Mauriac, Ignace B. Vergote, Jean‐Marc Nabholtz and G. Burton. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Wildlife Research, European Journal of Cancer and European Thyroid Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.